PMID- 16644687 OWN - NLM STAT- MEDLINE DCOM- 20060626 LR - 20190516 IS - 0012-1797 (Print) IS - 0012-1797 (Linking) VI - 55 IP - 5 DP - 2006 May TI - Phosphatidylinositol 3-kinase-dependent activation of akt, an essential signal for hyperthermia-induced heat-shock protein 72, is attenuated in streptozotocin-induced diabetic heart. PG - 1307-15 AB - We tested the hypothesis that phosphatidylinositol 3-kinase (PI 3-kinase)-dependent activation of Akt is essential for the expression of cardiac heat-shock protein 72 (HSP72) and that this pathway is impaired in the streptozotocin (STZ)-induced diabetic heart. STZ-induced male diabetic rats were treated with insulin (STZ-insulin group, n = 26) or vehicle (STZ-vehicle group, n = 61) for 3 weeks. Whole-body hyperthermia (43 degrees C for 20 min) was applied, and the heart was isolated 24 h later. Compared with control heart, hyperthermia-induced HSP72 expression and phosphorylation of Akt were attenuated in the STZ-vehicle heart. Pretreatment with wortmannin attenuated hyperthermia-induced HSP72 expression and phosphorylation of Akt. In isolated perfused heart experiments, the hyperthermia-treated STZ-vehicle heart showed poor left ventricular functional recovery during reperfusion after no-flow global ischemia compared with hyperthermia-treated control heart. Insulin treatment restored HSP72 expression and reperfusion-induced functional recovery. In cultured neonatal rat cardiomyocytes, hyperthermia-induced HSP72 expression was enhanced by insulin, together with tolerance against hypoxia-reoxygenation injury. Wortmannin and LY294002 inhibited hyperthermia-induced HSP72 expression and phosphorylation of Akt. Our results indicate that activation of Akt, in a PI 3-kinase-dependent manner, is essential for hyperthermia-induced HSP72 expression in association with cardioprotection, suggesting impairment of this signaling pathway in the STZ-induced diabetic heart, probably due to insulin deficiency. FAU - Shinohara, Tetsuji AU - Shinohara T AD - Department of Internal Medicine 1, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan. FAU - Takahashi, Naohiko AU - Takahashi N FAU - Ooie, Tatsuhiko AU - Ooie T FAU - Hara, Masahide AU - Hara M FAU - Shigematsu, Sakuji AU - Shigematsu S FAU - Nakagawa, Mikiko AU - Nakagawa M FAU - Yonemochi, Hidetoshi AU - Yonemochi H FAU - Saikawa, Tetsunori AU - Saikawa T FAU - Yoshimatsu, Hironobu AU - Yoshimatsu H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Diabetes JT - Diabetes JID - 0372763 RN - 0 (Androstadienes) RN - 0 (Blood Glucose) RN - 0 (Fatty Acids, Nonesterified) RN - 0 (HSP72 Heat-Shock Proteins) RN - 0 (Insulin) RN - 0 (Triglycerides) RN - 97C5T2UQ7J (Cholesterol) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - XVA4O219QW (Wortmannin) SB - IM MH - Androstadienes/pharmacology MH - Animals MH - Blood Glucose/metabolism MH - Body Weight MH - Cholesterol/blood MH - Diabetes Mellitus, Experimental/*enzymology MH - Enzyme Activation MH - Fatty Acids, Nonesterified/blood MH - Fever MH - HSP72 Heat-Shock Proteins/*biosynthesis MH - Heart/drug effects/*physiopathology MH - Insulin/blood MH - Male MH - Myocardium/*enzymology MH - Organ Size MH - Proto-Oncogene Proteins c-akt/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Triglycerides/blood MH - Wortmannin EDAT- 2006/04/29 09:00 MHDA- 2006/06/27 09:00 CRDT- 2006/04/29 09:00 PHST- 2006/04/29 09:00 [pubmed] PHST- 2006/06/27 09:00 [medline] PHST- 2006/04/29 09:00 [entrez] AID - 55/5/1307 [pii] AID - 10.2337/db05-0266 [doi] PST - ppublish SO - Diabetes. 2006 May;55(5):1307-15. doi: 10.2337/db05-0266.